News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
334,853 Results
Type
Article (10040)
Company Profile (15)
Press Release (324798)
Section
Business (97818)
Career Advice (402)
Deals (20741)
Drug Delivery (26)
Drug Development (45786)
Employer Resources (31)
FDA (9084)
Job Trends (9404)
News (176739)
Policy (18541)
Tag
Academia (1675)
Africa (277)
Alabama (30)
Allergies (29)
Alliances (23708)
Alzheimer's disease (739)
Approvals (9036)
Arizona (52)
Artificial intelligence (43)
Asia (24550)
Australia (5133)
Bankruptcy (175)
Best Places to Work (8689)
C2C Services and Suppliers (29486)
California (1113)
Canada (615)
Cancer (297)
Career advice (345)
CAR-T (29)
Cell therapy (72)
China (111)
Clinical research (36217)
Collaboration (89)
Colorado (53)
Connecticut (44)
COVID-19 (1213)
Cystic fibrosis (38)
Data (207)
Diabetes (55)
Diagnostics (3905)
Earnings (39681)
Europe (39732)
Events (50661)
Executive appointments (93)
FDA (9243)
Florida (186)
Funding (92)
Gene therapy (44)
GLP-1 (153)
Government (2514)
Healthcare (14234)
Hotbed/Location (239237)
Idaho (36)
Illinois (159)
Indiana (129)
Infectious disease (1224)
Inflammatory bowel disease (59)
Interviews (67)
IPO (10868)
Job creations (799)
Job search strategy (296)
Layoffs (63)
Legal (3885)
Liver cancer (42)
Lung cancer (67)
Maine (43)
Manufacturing (36)
Maryland (296)
Massachusetts (867)
Medical device (8750)
Medtech (8751)
Mergers & acquisitions (9837)
Metabolic disorders (120)
Michigan (65)
Minnesota (119)
Neuroscience (822)
New Hampshire (43)
New Jersey (437)
New York (417)
NextGen Class of 2024 (4935)
Non-profit (3923)
North Carolina (350)
Northern California (545)
Obesity (62)
Ohio (63)
Opinion (76)
Patents (45)
Pennsylvania (347)
People (26685)
Phase I (11490)
Phase II (16101)
Phase III (11929)
Pipeline (77)
Postmarket research (1036)
Preclinical (4269)
Press Release (58)
Rare diseases (74)
Real estate (2251)
Regulatory (12640)
Research institute (1415)
Resumes & cover letters (64)
South America (485)
Southern California (459)
Startups (1258)
Texas (143)
United States (5382)
Utah (32)
Vaccines (178)
Washington State (208)
Weight loss (39)
Date
Today (49)
Last 7 days (445)
Last 30 days (1412)
Last 365 days (25173)
2024 (17460)
2023 (27116)
2022 (31297)
2021 (34737)
2020 (36422)
2019 (34744)
2018 (25463)
2017 (18182)
2016 (17697)
2015 (19894)
2014 (10005)
2013 (6822)
2012 (7190)
2011 (7968)
2010 (7172)
334,853 Results for "origin agritech limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Origin Agritech Announces Long-Term Revenue Projections Across Key Product Lines Through 2029
July 23, 2024
·
2 min read
/C O R R E C T I O N -- Origin Agritech Limited/
Origin Agritech Ltd., an agriculture technology company, announced that the company has received an order for its hybrid corn worth RMB240 million, or roughly $35 million, from Muyuan Foods.
July 27, 2022
·
5 min read
Origin Agritech Receives a $35 Million Order from Muyuan Foods
Origin Agritech Ltd., an agriculture technology company, announced that the company has received an order for its hybrid corn worth RMB240 million, or roughly $35 million, from Muyuan Foods.
July 27, 2022
·
4 min read
Genetown
Cellular Origins and Cell and Gene Therapy Catapult Collaborate to Demonstrate Universal Automation of CGT Manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies, and the Cell and Gene Therapy Catapult, an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, announced a collaboration to demonstrate universal automation of CGT manufacturing.
May 29, 2024
·
4 min read
Press Releases
Cellular Origins and 3P innovation Collaborate to Accelerate Industrialisation of CGT Manufacturing
September 11, 2024
·
2 min read
Pharm Country
Origin Life Sciences Abstract Accepted for Presentation at 2024 Military Health System Research Symposium (MHSRS) Discussing Innovative Technologies and Devices for Treatment of Battlefield Wounds in Prolonged Care to Prevent Infection
Origin Life Sciences, Inc. announced that the Company’s abstract, titled: “NO: a Novel, Pathogen-Agnostic Therapy for Treatment-Resistant Wound Infections in the Warfighter,” has been accepted for presentation at 2024 Military Health System Research Symposium.
June 11, 2024
·
6 min read
Policy
PharmaTher Announces Assigned FDA Approval Goal Date of its Priority Original Abbreviated New Drug Application for Ketamine
PharmaTher Holdings Ltd. announced receipt of an Amendment Acknowledgment Letter for its Priority Original Abbreviated New Drug Application for Ketamine from the U.S. Food and Drug Administration and assigned a Generic Drug User Fee Amendments of 2022 goal date of October 29, 2024.
May 10, 2024
·
5 min read
Press Releases
Vera Therapeutics Completes Enrollment for Primary Endpoint in Pivotal Phase 3 ORIGIN 3 Trial of Atacicept in IgAN
September 12, 2024
·
6 min read
Drug Development
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
Vera Therapeutics, Inc. announced data presentations from its Phase 2b ORIGIN trial of atacicept in immunoglobulin A nephropathy, showing that atacicept stabilized kidney function through 72 weeks and led to rapid improvements in hematuria.
May 25, 2024
·
10 min read
Genetown
Thermo Fisher Scientific Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing
Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Gibco™ CTS™ OpTmizer™ One Serum-Free Medium *, a novel animal origin-free formulation designed specifically for clinical and commercial cell therapy manufacturing to deliver increased scalability and performance of T cell expansion.
April 11, 2024
·
4 min read
1 of 33,486
Next